Survival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hurthle cell carcinoma: a single center experience

BACKGROUND: Hurthle cell carcinoma makes up 3 to 5% of all thyroid cancers and is considered to be a true rarity. The aim of our study was to analyze clinical characteristics and survival rates of patients with Hurthle cell carcinoma. METHODS: Clinical data regarding basic demographic characteristic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Oluic, Branisav, Paunovic, Ivan, Loncar, Zlatibor, Djukic, Vladimir, Diklic, Aleksandar, Jovanovic, Milan, Garabinovic, Zeljko, Slijepcevic, Nikola, Rovcanin, Branislav, Micic, Dusan, Filipovic, Aleksandar, Zivaljevic, Vladan
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5445517/
https://ncbi.nlm.nih.gov/pubmed/28545571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3370-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados